Zhang, Y., Lu, S., Sun, F., Zhu, J., Zhen, Z., Cai, R., Que, Y., Zhang, Y., Song, M., Wu, L., Qin, Y., Wu, Y., Lin, X., Meng, C., Zhang, J., Zhu, D., Shao, Y., Wang, J., Huang, J. (2026). Longitudinal plasma and CSF ctDNA profiling as used to define therapeutic landmarks and compartmentalized clonal evolution in rhabdomyosarcoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11517